FREE Account Opening + No Clearing Fees

Eris Lifesciences Limited IPO (Eris Lifesciences IPO) Detail

June 16, 2017 - June 20, 2017

Eris Lifesciences IPO is a book built issue of Rs 1,741.16 crores. The issue is entirely an offer for sale of 2.89 crore shares.

Eris Lifesciences IPO bidding started from June 16, 2017 and ended on June 20, 2017. The allotment for Eris Lifesciences IPO was finalized on Friday, June 23, 2017. The shares got listed on BSE, NSE on June 29, 2017.

Eris Lifesciences IPO price band is set at ₹600 to ₹603 per share. The minimum lot size for an application is 24 Shares. The minimum amount of investment required by retail investors is ₹14,472.

The issue includes a reservation of up to 150,000 shares for employees offered at a discount of Rs 60 to the issue price.

Axis Capital Limited, Citigroup Global Markets India Private Limited and Credit Suisse Securities (India) Private Limited are the book running lead managers of the Eris Lifesciences IPO, while Link Intime India Private Ltd is the registrar for the issue.

Refer to Eris Lifesciences IPO RHP for detailed information.

Eris Lifesciences IPO Details

IPO Date June 16, 2017 to June 20, 2017
Listing Date June 29, 2017
Face Value ₹1 per share
Price Band ₹600 to ₹603 per share
Lot Size 24 Shares
Total Issue Size28,875,000 shares
(aggregating up to ₹1,741.16 Cr)
Offer for Sale28,875,000 shares of ₹1
(aggregating up to ₹[.] Cr)
Employee Discount Rs 60 per share
Issue Type Book Built Issue IPO
Listing At BSE, NSE

Eris Lifesciences IPO Reservation

Eris Lifesciences IPO a total of 15,948,750 shares are offered. QIB: 8,617,500 (54.03%), NII: 4,308,750 (27.02%), RII: 2,872,500 (18.01%). Minimum number of shares to be allotted to RIIs : 24 shares. Minimum number of shares to be allotted to NIIs (sNII/bNII) : 336 shares.

Investor Category Shares OfferedMaximum Allottees
Anchor Investor Shares Offered-NA
QIB Shares Offered8,617,500 (54.03%)NA
NII (HNI) Shares Offered4,308,750 (27.02%)
Retail Shares Offered2,872,500 (18.01%)119,687
Employee Shares Offered150,000 (0.94%)NA
Total Shares Offered15,948,750 (100%)

Eris Lifesciences IPO Timeline (Tentative Schedule)

Eris Lifesciences IPO opens on June 16, 2017, and closes on June 20, 2017.

IPO Open Date Friday, June 16, 2017
IPO Close Date Tuesday, June 20, 2017
Basis of Allotment Friday, June 23, 2017
Initiation of Refunds Tuesday, June 27, 2017
Credit of Shares to Demat Wednesday, June 28, 2017
Listing Date Thursday, June 29, 2017
Cut-off time for UPI mandate confirmation 5 PM on June 20, 2017

Eris Lifesciences IPO Lot Size

Investors can bid for a minimum of 24 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.

Application Lots Shares Amount
Retail (Min) 1 24 ₹14,472
Retail (Max) 13 312 ₹188,136
Lot Size Calculator

About Eris Lifesciences Limited

Incorporated in 2007, Eris Lifescience Ltd is Ahmedabad, Gujrat based pharmaceutical company engaged in research, development, manufacturing and selling of select therapeutic areas within the chronic and acute categories of the Indian Pharmaceutical Market.

Eris product portfolio is primarily focused on therapeutic areas which require the intervention of super specialist and specialist doctors such as Diabetologists, Endocrinologists Cardiologists, and Gastroenterologists.

Eris products in the chronic category cater primarily to the therapeutic areas including cardiovascular, anti-diabetics and neurology, chronic respiratory and chronic pain (analgesics).

In acute category, the product portfolio includes vitamins, gastroenterology, anti-infectives, gynaecology, cute respiratory, acute pain (analgesics), hepatoprotectives, hormones, hematology, dermatology, anti-obesity products and products for injury healing.

Eris Lifescience own and operate a manufacturing facility in Guwahati, Assam. They also outsource the manufacturing of certain of its products to 20 manufacturers. Eris strong sales team comprised of 1,310 marketing representatives.

Eris Lifescience Strengths:

• Focus on branded prescription based pharmaceutical products catering to lifestyle related disorders
• Portfolio of high volume and leading brands
• Focus on metro cities and class 1 towns in India which have higher incidence of lifestyle disorders and concentration of specialists and super specialists
• Multi-faceted product selection and engagement model leading to growth in prescription
• Strong sales, marketing and distribution capabilities

Company Financials

Summary of financial Information (Consolidated)
Particulars For the year/period ended (in Rs. Million)
31-Mar-16 31-Mar-15 31-Mar-14 31-Mar-13 31-Mar-12
Total Assets 3,973.59 3,572.85 2,705.99 1,718.05 1,019.67
Total Revenue 5,970.21 5,455.58 5,088.22 3,930.64 2,739.40
Profit After Tax 1,348.58 892.59 709.12 584.40 370.63

Objects of the Issue (Eris Lifesciences IPO Objectives)

The objects of the Offer are:
1. To achieve the benefits of listing the Equity Shares on the Stock Exchanges and
2. For the sale of up to 28,875,000 Equity Shares by the Selling Shareholders.

Eris Lifesciences IPO Review (Apply)

[Dilip Davda]  Investors may consider investment for medium to long term in this niche player having better penetration. Read detail review...

Eris Lifesciences IPO Subscription Status (Bidding Detail)

The Eris Lifesciences IPO is subscribed 3.29 times on Jun 20, 2017 5:00:00 PM. The public issue subscribed 3.51 times in the retail category, 4.68 times in the QIB category, and 0.45 times in the NII category. Check Day by Day Subscription Details (Live Status)

CategorySubscription (times)

Eris Lifesciences IPO Prospectus

Eris Lifesciences IPO Rating

Rating:Rated 4.0 stars
Vote Here ...

Eris Lifesciences IPO Listing Details

Listing Date June 29, 2017
BSE Script Code 540596
ISIN INE406M01024
Final Issue Price ₹603 per share

Pre-Open Session - NSE Pre-Open Session - BSE

Listing Day Trading Information

Price Details
Final Issue Price
Last Trade

Check IPO Performance…

Eris Lifesciences IPO Contact Details

Eris Lifesciences Limited
7th Floor, Commerce House IV,
Beside Shell Petrol Pump, 100 Feet Road,
Prahladnagar, Ahmedabad 380 015
Phone: +91 79 3045 1111

Eris Lifesciences IPO Registrar

Link Intime India Private Ltd

Phone: +91-22-4918 6270

Eris Lifesciences IPO - Buy or Not

Eris Lifesciences IPO Recommendation Summary

Review By Subscribe Neutral Avoid
Brokers 5 0 1
Members 0 0 0

Read All Reviews Post Your Review Manage Reviews

Eris Lifesciences IPO FAQs

Eris Lifesciences IPO is a main-board IPO of 28,875,000 equity shares of the face value of ₹1 aggregating up to ₹1,741.16 Crores. The issue is priced at ₹600 to ₹603 per share. The minimum order quantity is 24 Shares.

The IPO opens on June 16, 2017, and closes on June 20, 2017.

Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.

The Eris Lifesciences IPO opens on June 16, 2017 and closes on June 20, 2017.

Eris Lifesciences IPO lot size is 24 Shares, and the minimum amount required is ₹14,472.

You can apply in Eris Lifesciences IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.

The finalization of Basis of Allotment for Eris Lifesciences IPO will be done on Friday, June 23, 2017, and the allotted shares will be credited to your demat account by Wednesday, June 28, 2017. Check the Eris Lifesciences IPO allotment status.

The Eris Lifesciences IPO listing date is on June 29, 2017.
Open an Instant Account with Zerodha

Eris Lifesciences IPO Message Board

Ranked Members of Forum  Ranked Members | Most Liked Members



585. ipobazaar |   Link |Aug 11, 2017 9:53:35 AM
very poor listing....thats why GMP never guide please dont blame on market condition..SiS was listed yesterday and atleast opened on higher notes not like cochin shipyard...
i am lucky that i did not get allotment in shipyard...lets see what happens after listing...
584. VINAYERH |   Link |Aug 9, 2017 7:27:06 PM
Chek for AFHPK6980P
583. ASNI |   Link |Aug 8, 2017 5:52:17 PM
583.1. Compounder |   Link |Aug 9, 2017 1:39:19 AM
Decision to sell or hold depends on your holding period. On a v conservative basis, expect the next 3 year CAGR growth to be @ 25% (2017 PAT growth was 79%) which will take the EPS to Rs. 34.3 per share. Even at a P/E multiple of 35 (reasonable for a company with 25% earnings growth and secular domestic consumption story), this stock will be at minimum Rs. 1200 by FY 20. That''s a whopping 117% return from the current price. If this return does not satisfy some people, not sure what does. This is a long term coumpounding machine run by owner operator who has skin in the game. Just hold tight for the next 2 quarters at least till the results are out and see the magic.
582. Ajmera |   Link |Aug 5, 2017 6:35:51 PM
target may be appox. 940-1000 in 3-4 month
581. Tarun D Agrawal |   Link |Jul 30, 2017 4:53:42 PM
Will the share price go up?
581.1. Mr. Ghosh |   Link |Jul 30, 2017 5:27:17 PM
Wait for few days.
580. RT |   Link |Jul 26, 2017 9:20:04 PM
Eris and Laurus both are going down.
579. DSR |   Link |Jul 24, 2017 11:16:13 PM
IPO Mentor IPO Mentor (600+ Posts, 400+ Likes)
This is now close to open price. I believe for those wh did not get allotment now is the god time t buy or ..should wait more for the market to correct...secondary market has become too risky ..
578. SACHIN MEHTA |   Link |Jul 19, 2017 4:58:29 PM
Hello Sapta Sir and Eagle eye Mam...Please suggest me about Eris Lifescience..Whether we hold or sell the stock..and if hold how much time to hold for good return...and what is your views on this stock?
578.1. Raynmaker |   Link |Jul 19, 2017 5:17:27 PM
Wait till the first result, minimum.
577. Compounder |   Link |Jul 16, 2017 2:14:01 AM
Great to see Eris on top of MF''s buying list.

Disclosure: Invested as HNI in IPO.
576. Dn |   Link |Jul 14, 2017 12:54:05 PM
Bought 50 shares@714 & another 50 shares @ 702
Hold or sell
576.1. Prem Nookala |   Link |Jul 14, 2017 5:19:59 PM
It''s a good equity fundamentally. You could go for longterm.
575. nicks Jain |   Link |Jul 14, 2017 10:49:29 AM
IPO Mentor IPO Mentor (700+ Posts, 800+ Likes)
Definitely good Stocks to keep in Portfolio.
Its only for long term investors....
574. wow |   Link |Jul 14, 2017 9:08:12 AM
its zooming now
573. AHM |   Link |Jul 13, 2017 9:26:02 PM
Eris Life science Fundamentally Good company
One can continue to hold for ST/MT.

Tomorrow again we will upside
Today closing price 676.95
572. RT |   Link |Jul 13, 2017 7:39:18 PM
I am Eris Lifesciences and now my turn to show the game.
571. BestAnalyst |   Link |Jul 6, 2017 8:17:15 PM
Eris is not moving ... And tejas is running like a horse.
571.1. Raynmaker |   Link |Jul 13, 2017 3:48:19 PM
Check now
571.2. nicks Jain |   Link |Jul 13, 2017 4:13:24 PM
IPO Mentor IPO Mentor (700+ Posts, 800+ Likes)
In Equity mkt, lots of patience Needed
Just Like in ERIS,we were sure and confident to keep hold
570. nicks Jain |   Link |Jul 13, 2017 4:06:04 PM
IPO Mentor IPO Mentor (700+ Posts, 800+ Likes)
Eris rocks today
Still holding 7 lots of IPO
569. Raynmaker |   Link |Jul 13, 2017 3:38:49 PM
37 L shares traded today and Closed At 696, up 12.6%. Where are the people who were waiting to buy at 550-570?
@Septa ji profits Mubarak ho.
I am still holding and will not sell below 1,000
568. Raynmaker |   Link |Jul 6, 2017 7:52:44 AM
Delivery volume since last two days over 50%. Yesterday jumped to 62%
568.2. Raynmaker |   Link |Jul 6, 2017 2:00:13 PM
Now that AU allocation is out and funds will be released, let''s see how this one behaves. Allocation has been low in HNI
568.3. Raynmaker |   Link |Jul 11, 2017 3:41:37 PM
Hit a High of 632. It was magical. Just zoomed and zoomed and zoomed. Still holding, wont let go below 1,000, whatever time it takes.
567. DSR |   Link |Jul 9, 2017 8:52:23 PM
IPO Mentor IPO Mentor (600+ Posts, 400+ Likes)
One off track question:

I am using HDFsec for trading: My demat account, trading and savings account all are with HDFC.

I am now thinking of opening demat account for my wife. Could anyone suggest where should I open it ? And would it be possible to use the new account for trading through HDFCsec?
566. Chem cho |   Link |Jun 29, 2017 10:19:16 AM
IPO Guru IPO Guru (2500+ Posts, 2700+ Likes)
Good buy at Rs 560 to Rs 570
wait and watch
I always come on site at time of listing ,
where experts do not dare to give comments from 10 am to 3 pm

bye no more time to spare in this site
566.13. Maniac |   Link |Jul 5, 2017 4:58:13 PM
@ Shareview

Thanks mate ...:)
566.14. Raynmaker |   Link |Jul 13, 2017 10:21:29 AM
Chem cho did you buy any at 560-570?